Genky DrugStores reports the trends in FY2025 sales, same-store sales, and customer visits, along with updates on store expansions, renovations, and closures. The company continues its store strategy into FY2026, closely monitoring sales and customer traffic movements.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9267","jir_company_name":"Genky DrugStores Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-07-28","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/07\/9267-20260728-01.pdf","jir_short_summary":"Genky DrugStores reports the trends in FY2025 sales, same-store sales, and customer visits, along with updates on store expansions, renovations, and closures. The company continues its store strategy into FY2026, closely monitoring sales and customer traffic movements.","jir_summary":"### Performance Overview\nGenky DrugStores' FY2025 sales remained flat at 105.0% compared to the same period last year, while same-store sales declined slightly to 97.9%. The number of stores was maintained at 534, with no change from the previous period, despite opening new stores, renovations, and closures. The company is also monitoring trends in customer numbers and spend per customer, continuing efforts to improve performance.\n\n### Future Outlook and Strategy\nIn FY2026, the company plans to continue expanding and standardizing stores, aiming for stable growth in sales and customer traffic. It will proceed with opening new stores and renovations, strengthening a community-focused sales approach. Monitoring sales and customer trends, the company intends to work on improving profitability.","jir_financial_highlights":"Sales YoY (All Stores): 105.0 (Up 0.4 points YoY (July 2026))\nSales YoY (Existing Stores): 97.9 (Down 2.1 points YoY (July 2026))\nNumber of Stores: 534 (No change from the previous term (June 2026))","jir_category":"","jir_hashtags":"#GenkyDrugStores, #FinancialResults, #JapaneseStocks","jir_key_figures":"Sales (All Stores): 105.0% (YoY)\nSame-store sales: 97.9% (YoY)\nNumber of stores: 534 stores (as of June 2026)","jir_meta_title":"[Genky DrugStores] FY2025 Performance and Store Strategy | July 2026","jir_meta_description":"An overview of Genky DrugStores' FY2025 financial results and FY2026 store strategies. Detailed insights into sales, store numbers, and future outlook.","jir_og_title":"[Genky DrugStores] FY2025 Earnings and Store Strategy | July 2026","jir_og_description":"A detailed explanation of Genky DrugStores' FY2025 financial results and future store strategies. Information on sales, store numbers, and outlook.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":9174,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-88911","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n